Faster Patient Enrollment Through Smart Trials Management

By Amanda Foster 31/07/2026 2 min read 76 views

Patient enrollment delays in clinical trials often occur due to operational processes, not a lack of participants. These processes can slow enrollment and push key study milestones off schedule, leading to increased pressure on study sites.

Modern clinical trial supply management software includes Randomization and Trial Supply Management (RTSM) capabilities that automate many operational tasks, supporting faster patient enrollment and randomization.

Most patient enrollment follows a standard workflow, with each completed step moving a patient closer to enrollment. However, manual coordination can cause delays, affecting the entire study timeline.

Duplicate data entry, delayed communication between sites, sponsors, and supply teams, and human error in treatment assignment or inventory tracking can lead to protocol deviations and additional review.

Eligibility verification and patient randomization are common bottlenecks. The investigator must verify patient data, which can involve emails, phone calls, or sponsor approval, causing delays.

A potential participant undergoes screening, and the investigator reviews whether they meet the study protocol’s eligibility requirements, including inclusion and exclusion criteria, medical history, and health checks.

Once the investigator confirms eligibility, the site enters the participant’s information into the RTSM system, which applies the protocol’s predefined randomization rules and assigns the patient to the appropriate treatment arm.

The RTSM system automatically allocates the correct investigational product based on the study protocol and updates the site inventory in real-time, giving Clinical Operations and supply teams visibility into investigational product inventory and patient enrollment.

If investigational product inventory falls below a threshold, the RTSM system triggers resupply, ensuring sites have enough product available to continue enrolling and treating patients.

RTSM addresses bottlenecks by connecting patient enrollment, randomization, and investigational product management in a single automated workflow, allowing site staff to move forward with treatment without waiting for manual approvals.

Speed in clinical trials depends on efficiently completing each operational step after a patient qualifies for the study. Small delays can create bottlenecks, but RTSM can help by automating workflows and ensuring consistent completion of each step according to the study protocol.

By evaluating RTSM solutions, such as a demo on automated workflows, clinical trial sponsors can improve patient enrollment and randomization, ultimately supporting faster and more efficient clinical trials.

The use of RTSM can also help reduce the risk of protocol deviations and additional review, as it automates many operational tasks and ensures that each step is completed quickly and consistently according to the study protocol.

RTSM provides real-time visibility into investigational product inventory and patient enrollment, allowing Clinical Operations teams to identify potential issues before they affect study timelines.

This can help reduce delays and improve the overall efficiency of clinical trials, ultimately supporting the development of new treatments and therapies.

As clinical trials continue to evolve, the use of RTSM and other automated technologies will likely play an increasingly important role in supporting faster and more efficient clinical trials.

Clinical trials will become more efficient.